Patrick Wilmerding
Direttore/Membro del Consiglio presso Irresistible Materials Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Sanjeev Luther | M | 62 |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | 9 anni |
Robert G. L. Shorr | M | 71 |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | - |
Howard Jonas | M | 68 |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | 11 anni |
Alex Robinson | M | - |
Irresistible Materials Ltd.
Irresistible Materials Ltd. Electronics/AppliancesConsumer Durables Irresistible Materials Ltd. develops next generation of photo-resist materials the semiconductor industry. The firm's photo-resist is a material that undergoes a change in its physical and chemical properties upon exposure to radiation that allows for the formation of a relief pattern in a material. The company was founded by Elwyn Shelley, Alex Robinson and David Alexander Ure in 2010 and is headquartered in Swansea Waterfront, the United Kingdom. | 14 anni |
David Alexander Ure | M | - |
Irresistible Materials Ltd.
Irresistible Materials Ltd. Electronics/AppliancesConsumer Durables Irresistible Materials Ltd. develops next generation of photo-resist materials the semiconductor industry. The firm's photo-resist is a material that undergoes a change in its physical and chemical properties upon exposure to radiation that allows for the formation of a relief pattern in a material. The company was founded by Elwyn Shelley, Alex Robinson and David Alexander Ure in 2010 and is headquartered in Swansea Waterfront, the United Kingdom. | 14 anni |
Mark Shepherd | M | - |
Irresistible Materials Ltd.
Irresistible Materials Ltd. Electronics/AppliancesConsumer Durables Irresistible Materials Ltd. develops next generation of photo-resist materials the semiconductor industry. The firm's photo-resist is a material that undergoes a change in its physical and chemical properties upon exposure to radiation that allows for the formation of a relief pattern in a material. The company was founded by Elwyn Shelley, Alex Robinson and David Alexander Ure in 2010 and is headquartered in Swansea Waterfront, the United Kingdom. | - |
A Joseph Stern | M | - |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | - |
Eric Cutsem | M | - |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | - |
Craig Moskowitz | M | - |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | - |
Chi Van Dang | M | - |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | - |
Mark Volanthen | M | - |
Irresistible Materials Ltd.
Irresistible Materials Ltd. Electronics/AppliancesConsumer Durables Irresistible Materials Ltd. develops next generation of photo-resist materials the semiconductor industry. The firm's photo-resist is a material that undergoes a change in its physical and chemical properties upon exposure to radiation that allows for the formation of a relief pattern in a material. The company was founded by Elwyn Shelley, Alex Robinson and David Alexander Ure in 2010 and is headquartered in Swansea Waterfront, the United Kingdom. | - |
David Coleman | M | - |
Irresistible Materials Ltd.
Irresistible Materials Ltd. Electronics/AppliancesConsumer Durables Irresistible Materials Ltd. develops next generation of photo-resist materials the semiconductor industry. The firm's photo-resist is a material that undergoes a change in its physical and chemical properties upon exposure to radiation that allows for the formation of a relief pattern in a material. The company was founded by Elwyn Shelley, Alex Robinson and David Alexander Ure in 2010 and is headquartered in Swansea Waterfront, the United Kingdom. | - |
Aaron Drillick | M | - |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | - |
Alan Brown | M | - |
Irresistible Materials Ltd.
Irresistible Materials Ltd. Electronics/AppliancesConsumer Durables Irresistible Materials Ltd. develops next generation of photo-resist materials the semiconductor industry. The firm's photo-resist is a material that undergoes a change in its physical and chemical properties upon exposure to radiation that allows for the formation of a relief pattern in a material. The company was founded by Elwyn Shelley, Alex Robinson and David Alexander Ure in 2010 and is headquartered in Swansea Waterfront, the United Kingdom. | 11 anni |
Alexandra L. McClelland | F | - |
Irresistible Materials Ltd.
Irresistible Materials Ltd. Electronics/AppliancesConsumer Durables Irresistible Materials Ltd. develops next generation of photo-resist materials the semiconductor industry. The firm's photo-resist is a material that undergoes a change in its physical and chemical properties upon exposure to radiation that allows for the formation of a relief pattern in a material. The company was founded by Elwyn Shelley, Alex Robinson and David Alexander Ure in 2010 and is headquartered in Swansea Waterfront, the United Kingdom. | 13 anni |
Daniel Armbrust | M | - |
Irresistible Materials Ltd.
Irresistible Materials Ltd. Electronics/AppliancesConsumer Durables Irresistible Materials Ltd. develops next generation of photo-resist materials the semiconductor industry. The firm's photo-resist is a material that undergoes a change in its physical and chemical properties upon exposure to radiation that allows for the formation of a relief pattern in a material. The company was founded by Elwyn Shelley, Alex Robinson and David Alexander Ure in 2010 and is headquartered in Swansea Waterfront, the United Kingdom. | - |
Zuzana Zachar | M | - |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | - |
Paul Bingham | M | - |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | - |
Shmuel Levinger | M | - |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 11 | 57.89% |
Regno Unito | 8 | 42.11% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Patrick Wilmerding
- Contatti personali